open access

Vol 88, No 6 (2017)
Research paper
Published online: 2017-06-30
Get Citation

The utility of maternal mean platelet volume levels for early onset neonatal sepsis prediction of term infants

Yasemin Cekmez1, Merve Dizdar Güleçoğlu, Cemile Özcan, Leyla Karadeniz, Gürkan Kıran
DOI: 10.5603/GP.a2017.0058
·
Pubmed: 28727130
·
Ginekol Pol 2017;88(6):312-314.
Affiliations
  1. Science Health University, Umraniye Medical and Research Hospital, Obstetrics Department, Turkey, Turkey

open access

Vol 88, No 6 (2017)
ORIGINAL PAPERS Obstetrics
Published online: 2017-06-30

Abstract

Objectives: This study is aimed to evaluate the role of maternal mean platelet volume (MPV) levels for antenatal prediction marker of early onset neonatal sepsis in term infants born to mothers who have low infection risk.

Material and methods: A total of 62 pregnant women who gave birth in our hospital and whose neonates were admitted to a third level Neonatal Intensive Care Unit due to confirmed neonatal sepsis between January 2010 and May 2016 were selected as a study group. Within the same period, 68 women who gave birth to healthy neonates were enrolled as a control group. We compared maternal MPV values which were evaluated before delivery. The receiver operating characteristic (ROC) curves were drawn to evaluate the values maternal MPV in the diagnosis of neonatal sepsis.

Results: MPV levels were detected statistically higher in the study group than the control group (8.27 ± 1.85 vs. 8.98 ± 1.16) (p = 0.001).

Conclusion: The maternal serum MPV level is a clinically useful, non-invasive and reliable marker in antenatal prediction of EOS.

Abstract

Objectives: This study is aimed to evaluate the role of maternal mean platelet volume (MPV) levels for antenatal prediction marker of early onset neonatal sepsis in term infants born to mothers who have low infection risk.

Material and methods: A total of 62 pregnant women who gave birth in our hospital and whose neonates were admitted to a third level Neonatal Intensive Care Unit due to confirmed neonatal sepsis between January 2010 and May 2016 were selected as a study group. Within the same period, 68 women who gave birth to healthy neonates were enrolled as a control group. We compared maternal MPV values which were evaluated before delivery. The receiver operating characteristic (ROC) curves were drawn to evaluate the values maternal MPV in the diagnosis of neonatal sepsis.

Results: MPV levels were detected statistically higher in the study group than the control group (8.27 ± 1.85 vs. 8.98 ± 1.16) (p = 0.001).

Conclusion: The maternal serum MPV level is a clinically useful, non-invasive and reliable marker in antenatal prediction of EOS.

Get Citation

Keywords

early onset neonatal sepsis, mean platelet volum, pregnancy, infection

About this article
Title

The utility of maternal mean platelet volume levels for early onset neonatal sepsis prediction of term infants

Journal

Ginekologia Polska

Issue

Vol 88, No 6 (2017)

Article type

Research paper

Pages

312-314

Published online

2017-06-30

DOI

10.5603/GP.a2017.0058

Pubmed

28727130

Bibliographic record

Ginekol Pol 2017;88(6):312-314.

Keywords

early onset neonatal sepsis
mean platelet volum
pregnancy
infection

Authors

Yasemin Cekmez
Merve Dizdar Güleçoğlu
Cemile Özcan
Leyla Karadeniz
Gürkan Kıran

References (13)
  1. Gandhi S, Ranjan KP, Ranjan N, et al. Incidence of neonatal sepsis in tertiary care hospital: An overview. International Journal of Medical Science and Public Health. 2013; 2(3): 548.
  2. Rasul CH, Hassan MA, Habibullah M. Neonatal sepsis and use of antibiotic in a tertiary care hospital. Pakistan Journal of Medical Sciences. 2007; 23(1): 78–81.
  3. Tripathi S, Malik GK. Neonatal Sepsis: past, present and future; a review article. Internet Journal of Medical Update - EJOURNAL. 2010; 5(2).
  4. Lim WHo, Lien R, Huang YC, et al. Prevalence and pathogen distribution of neonatal sepsis among very-low-birth-weight infants. Pediatr Neonatol. 2012; 53(4): 228–234.
  5. Fan Y, Yu JL. Umbilical blood biomarkers for predicting early-onset neonatal sepsis. World J Pediatr. 2012; 8(2): 101–108.
  6. Saldir M, Tunc T, Cekmez F, et al. Endocan and Soluble Triggering Receptor Expressed on Myeloid Cells-1 as Novel Markers for Neonatal Sepsis. Pediatr Neonatol. 2015; 56(6): 415–421.
  7. Cekmez F, Canpolat FE, Cetinkaya M, et al. Diagnostic value of resistin and visfatin, in comparison with C-reactive protein, procalcitonin and interleukin-6 in neonatal sepsis. Eur Cytokine Netw. 2011; 22(2): 113–117.
  8. Çekmez Y, Çekmez F, Özkaya E, et al. Proadrenomedullin and serum amyloid A as a predictor of subclinical chorioamnionitis in preterm premature rupture of membranes. J Interferon Cytokine Res. 2013; 33(11): 694–699.
  9. Oria de Rueda Salguero O, Beceiro Mosquera J, Barrionuevo Gonzalez M, et al. [Cord blood procalcitonin in the assessment of early-onset neonatal sepsis]. An Pediatr (Barc). 2016; 14.
  10. Verstraete EH, Blot K, Mahieu L, et al. Prediction models for neonatal health care-associated sepsis: a meta-analysis. Pediatrics. 2015; 135(4): e1002–e1014.
  11. Cekmez F, Tanju IA, Canpolat FE, et al. Mean platelet volume in very preterm infants: a predictor of morbidities? Eur Rev Med Pharmacol Sci. 2013; 17(1): 134–137.
  12. Catal F, Tayman C, Tonbul A, et al. Mean platelet volume (MPV) may simply predict the severity of sepsis in preterm infants. Clin Lab. 2014; 60(7): 1193–1200.
  13. Ahmad MS, Waheed A. Platelet counts, MPV and PDW in culture proven and probable neonatal sepsis and association of platelet counts with mortality rate. J Coll Physicians Surg Pak. 2014; 24(5): 340–344.

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk
tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl